222 related articles for article (PubMed ID: 15924607)
1. Clinico-cytological study of uterine papillary serous carcinoma.
Hagiwara T; Kaku T; Kobayashi H; Hirakawa T; Nakano H
Cytopathology; 2005 Jun; 16(3):125-31. PubMed ID: 15924607
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.
Creasman WT; Kohler MF; Odicino F; Maisonneuve P; Boyle P
Gynecol Oncol; 2004 Dec; 95(3):593-6. PubMed ID: 15581969
[TBL] [Abstract][Full Text] [Related]
3. [Uterine papillary serous carcinoma and papillary endometrial carcinoma: analysis of clinical biological behaviors of 56 cases].
Sun X; Shi S; Sheng X
Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):8-11. PubMed ID: 8758810
[TBL] [Abstract][Full Text] [Related]
4. [Uterine papillary serous carcinoma--one kind of special type of uterine endometrial carcinoma].
Wu M; Lang J; Guo L
Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):3-7. PubMed ID: 8758809
[TBL] [Abstract][Full Text] [Related]
5. Cervical cytology in serous and endometrioid endometrial cancer.
Roelofsen T; Geels YP; Pijnenborg JM; van Ham MA; Zomer SF; van Tilburg JM; Snijders MP; Siebers AG; Bulten J; Massuger LF
Int J Gynecol Pathol; 2013 Jul; 32(4):390-8. PubMed ID: 23722512
[TBL] [Abstract][Full Text] [Related]
6. p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes.
Zheng W; Cao P; Zheng M; Kramer EE; Godwin TA
Gynecol Oncol; 1996 May; 61(2):167-74. PubMed ID: 8626128
[TBL] [Abstract][Full Text] [Related]
7. Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients.
Grice J; Ek M; Greer B; Koh WJ; Muntz HG; Cain J; Tamimi H; Stelzer K; Figge D; Goff BA
Gynecol Oncol; 1998 Apr; 69(1):69-73. PubMed ID: 9571001
[TBL] [Abstract][Full Text] [Related]
8. Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression.
Nordström B; Strang P; Lindgren A; Bergström R; Tribukait B
Anticancer Res; 1996; 16(2):899-904. PubMed ID: 8687148
[TBL] [Abstract][Full Text] [Related]
9. What staging surgery should be performed on patients with uterine papillary serous carcinoma?
Geisler JP; Geisler HE; Melton ME; Wiemann MC
Gynecol Oncol; 1999 Sep; 74(3):465-7. PubMed ID: 10479511
[TBL] [Abstract][Full Text] [Related]
10. Cytologic findings of cervicovaginal smears in women with uterine papillary serous carcinoma.
Park JY; Kim HS; Hong SR; Chun YK
J Korean Med Sci; 2005 Feb; 20(1):93-7. PubMed ID: 15716611
[TBL] [Abstract][Full Text] [Related]
11. Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype?
Skaznik-Wikiel ME; Ueda SM; Frasure HE; Rose PG; Fleury A; Grumbine FC; Fader AN
Acta Cytol; 2011; 55(3):255-60. PubMed ID: 21525737
[TBL] [Abstract][Full Text] [Related]
12. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma: treatment implications.
Aquino-Parsons C; Lim P; Wong F; Mildenberger M
Gynecol Oncol; 1998 Oct; 71(1):83-6. PubMed ID: 9784324
[TBL] [Abstract][Full Text] [Related]
13. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.
Kelly MG; O'Malley D; Hui P; McAlpine J; Dziura J; Rutherford TJ; Azodi M; Chambers SK; Schwartz PE
Gynecol Oncol; 2004 Dec; 95(3):469-73. PubMed ID: 15581948
[TBL] [Abstract][Full Text] [Related]
14. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
Kelly MG; O'malley DM; Hui P; McAlpine J; Yu H; Rutherford TJ; Azodi M; Schwartz PE
Gynecol Oncol; 2005 Sep; 98(3):353-9. PubMed ID: 16005947
[TBL] [Abstract][Full Text] [Related]
15. Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma.
Geisler JP; Sorosky JI; Duong HL; Buekers TE; Geisler MJ; Sood AK; Anderson B; Buller RE
Gynecol Oncol; 2001 Dec; 83(3):501-3. PubMed ID: 11733962
[TBL] [Abstract][Full Text] [Related]
16. Papillary serous carcinoma--a less radio-sensitive subtype of endometrial cancer.
Martin JD; Gilks B; Lim P
Gynecol Oncol; 2005 Aug; 98(2):299-303. PubMed ID: 15964062
[TBL] [Abstract][Full Text] [Related]
17. Uterine papillary serous carcinoma: patterns of metastatic spread.
Goff BA; Kato D; Schmidt RA; Ek M; Ferry JA; Muntz HG; Cain JM; Tamimi HK; Figge DC; Greer BE
Gynecol Oncol; 1994 Sep; 54(3):264-8. PubMed ID: 8088602
[TBL] [Abstract][Full Text] [Related]
18. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of endometrial glandular dysplasia precedes uterine papillary serous carcinoma.
Zheng W; Liang SX; Yi X; Ulukus EC; Davis JR; Chambers SK
Int J Gynecol Pathol; 2007 Jan; 26(1):38-52. PubMed ID: 17197896
[TBL] [Abstract][Full Text] [Related]
20. Practice patterns of SGO members for stage IIIA endometrial cancer.
Lee CM; Slomovitz BM; Greer M; Sharma S; Gregurich MA; Burke T; Lu KH; Ramondetta LM
Gynecol Oncol; 2005 Jul; 98(1):77-83. PubMed ID: 15907988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
